Cleveland Clinic emphasizes bone health in lung transplant patients

A recent study from Cleveland Clinic highlights the importance of managing bone health in lung transplant patients. It found that high-dose glucocorticoid therapy after transplantation significantly increases the risk of osteoporosis and fractures. The study analyzed data from over 1,000 lung transplant patients and identified strong predictors of post-transplant fractures, including pre-existing osteoporosis and a history of smoking or alcohol use. The use of denosumab, a medication for osteoporosis, was linked to a 65% reduction in fracture risk. Cleveland Clinic emphasizes the need for comprehensive bone health evaluations for all lung transplant candidates. Their program includes assessing risk factors and developing personalized medication plans to help prevent osteoporosis-related complications.